← All trials
NCT06964230
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 26, 2026
- Primary completion
- Apr 30, 2031
- Completion date
- Jun 30, 2031
- First posted
- May 9, 2025
- Last posted
- May 9, 2025
- Enrollment
- 376
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- T3D Therapeutics, Inc.Lead sponsor
- T3D Therapeutics, Inc.Official
- T3D Therapeutics, Inc.Sponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.